Comparison of GreenLight Laser Photoselective Vaporization and Thulium Laser Enucleation for Nonmuscle Invasive Bladder Cancer.

Q2 Medicine

Photomedicine and laser surgery Pub Date : 2018-07-01 Epub Date: 2018-05-02 DOI:10.1089/pho.2018.4440

Meihua Lu, Xiaolong Liu

{"title":"Comparison of GreenLight Laser Photoselective Vaporization and Thulium Laser Enucleation for Nonmuscle Invasive Bladder Cancer.","authors":"Meihua Lu, Xiaolong Liu","doi":"10.1089/pho.2018.4440","DOIUrl":null,"url":null,"abstract":"Objective: To evaluate the safety and efficacy of GreenLight laser vaporization and thulium laser enucleation for nonmuscle invasive bladder cancer (NMIBC).Patients and methods: A total of 150 patients of NMIBC who underwent either GreenLight laser vaporization (Group A, n = 78) or thulium laser enucleation (Group B, n = 72) were analyzed, respectively. The preoperative, intraoperative, and postoperative clinical data were recorded and compared in the two groups.Results: All patients were successfully treated with GreenLight laser vaporization or thulium laser enucleation. No significant difference was observed in operation time, catheterization time, and postoperative hospital stay time between them. No complications such as obturator nerve reflex, bladder perforation, overhydration, or intraoperative or postoperative bleeding occurred in all patients. The patients were followed up for 12 months; during the period the recurrence rate was 10.26% (8/78) and 9.72% (7/72), respectively, between Groups A and B.Conclusions: Both GreenLight laser vaporization and thulium laser enucleation are effective and safe treatments for patients with NMIBC. Long-term clinical trials are necessary to increase the current scientific evidence base.","PeriodicalId":20117,"journal":{"name":"Photomedicine and laser surgery","volume":"36 7","pages":"383-385"},"PeriodicalIF":0.0000,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/pho.2018.4440","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Photomedicine and laser surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/pho.2018.4440","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/5/2 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 4

Abstract

Objective: To evaluate the safety and efficacy of GreenLight laser vaporization and thulium laser enucleation for nonmuscle invasive bladder cancer (NMIBC).

Patients and methods: A total of 150 patients of NMIBC who underwent either GreenLight laser vaporization (Group A, n = 78) or thulium laser enucleation (Group B, n = 72) were analyzed, respectively. The preoperative, intraoperative, and postoperative clinical data were recorded and compared in the two groups.

Results: All patients were successfully treated with GreenLight laser vaporization or thulium laser enucleation. No significant difference was observed in operation time, catheterization time, and postoperative hospital stay time between them. No complications such as obturator nerve reflex, bladder perforation, overhydration, or intraoperative or postoperative bleeding occurred in all patients. The patients were followed up for 12 months; during the period the recurrence rate was 10.26% (8/78) and 9.72% (7/72), respectively, between Groups A and B.

Conclusions: Both GreenLight laser vaporization and thulium laser enucleation are effective and safe treatments for patients with NMIBC. Long-term clinical trials are necessary to increase the current scientific evidence base.

查看原文本刊更多论文

绿光激光选择性汽化与铥激光去核治疗非肌性浸润性膀胱癌的比较。

目的:评价绿光激光汽化联合铥激光去核治疗非肌性浸润性膀胱癌的安全性和有效性。患者和方法:分析150例分别行GreenLight激光汽化(A组，n = 78)和铥激光去核(B组，n = 72)的NMIBC患者。记录两组患者术前、术中、术后临床资料并进行比较。结果:所有患者均行绿光激光汽化或铥激光去核治疗。两组患者的手术时间、置管时间及术后住院时间均无显著差异。所有患者均未出现闭孔神经反射、膀胱穿孔、过度水合、术中术后出血等并发症。随访12个月;A组和b组术后复发率分别为10.26%(8/78)和9.72%(7/72)。结论:绿光激光汽化和铥激光去核是治疗NMIBC有效、安全的治疗方法。为了增加现有的科学证据基础，长期临床试验是必要的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Photomedicine and laser surgery 医学-外科

CiteScore

4.50

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Photobiomodulation, Photomedicine, and Laser Surgery (formerly Photomedicine and Laser Surgery) is the essential journal for cutting-edge advances and research in phototherapy, low-level laser therapy (LLLT), and laser medicine and surgery. The Journal delivers basic and clinical findings and procedures to improve the knowledge and application of these techniques in medicine.